13.00 - 13.15

SESSION I - PROF. ELIEZER RACHMILEWITZ SESSION CHAIRS: Osman İlhan, Serdar Bedii Omay

13.15 - 13.25 How Hematology Changed During the Days in the Life of Eliezer Rachmilewitz Giuseppe Saglio

13.25 - 13.45 Lessons Learned From CML (Inaugural Lecture Dedicated to Eliezer Rachmilewitz) Robert Gale

13.45 - 14.05 Von Willebrand Disease, Laboratory Issues Pierre Toulon

14.05 - 14.25 Tumor Evolution in Genomic Era and Darwin Emin Kansu

14.25 - 14.45 The Role of T Cell Immunotherapy in the Management of Aggressive Lymphomas Hanan Hamed

14.45 - 15.00 Best Abstract Presentation (Eliezer Rachmilewitz Price) - Analysis of Genetic Abnormalities in Newly Diagnosed Acute Lymphoblastic Leukemia Patients at King Faisal Specialist Hospital & Research CentreOsamah Khojah

15.00 - 15.30

SESSION II - PROF. EKREM MÜFTÜOĞLU SESSION - MYELODYSPLASTIC SYNDROME CHAIRS: Tapan Kadia, Zahit Bolaman, Orhan Ayyıldız

15.30 - 16.00 Paroxysmal Nocturnal Hemoglobinuria Hanan Hamed

16.00 - 16.30 Prognostic Molecular Markers in MDS Mustafa Çetiner

16.30 - 17.00 Current Treatment of MDS Tapan Kadia

17.00 - 17.30 New Therapies in MDS Tapan Kadia

HEMATOLOGY PROGRAM

OPENING REMARKS - Birol Güvenç - Giuseppe Saglio

17 OCTOBER 2018

COFFEE BREAK

17.30 - 18.00

SESSION III - PROF. ATİLLA YALÇIN SESSION - CHRONIC MYELOPROLIFERATIVE DISORDERS CHAIRS: Tariq Mughal, Ferit Avcu, Fahri Şahin

18.00 - 18.30 Current Treatment of Myeloproliferative Neoplasms Haifa Kathrin Al-Ali

18.30 - 19.00 Jak2 Inhibıtors and What Comes Next for Patients withBCR-ABL1- Negatıive Myeloproliferative NeoplasmsTariq Mughal

19.00 - 19.30 Molecular Markers and New Prognostic Scores in MPNs Tariq Mughal

19.30 - 20.30 POSTER PRESENTATIONS SESION 1 CHAIRS: Ahmet İfran, Ahmet Öztürk, Ozan Salim

COFFEE BREAK

07.30 - 08.15

SESSION IV - MULTIPLE MYELOMA CHAIRS: Angelo Maiolino, Levent Ündar

08.30 - 09.00 First Line Therapy for Multiple Myeloma Guray Saydam

09.00 - 09.30 Treatmens in Relapsed / Refractory Multiple Myeloma Angelo Maiolino

09.30 - 10.00 New Drugs for Multiple Myeloma Angelo Maiolino

10.00 - 10.30

SESSION V - ACUTE MYELOID LEUKEMIACHAIRS: Alessandro Cignetti, Seçkin Çağırgan, Osman

Özcebe

10.30 - 11.00 AML Therapy: What is Essential and What is Investigational Tapan Kadia

11.00 - 11.30 Molecular Characterization and Follow Up in AML, Practical Issues Mehmet Yılmaz

11:30 - 12:00 APL: A Special Kind of AML with a Different Treatment Alessandro Cignetti

12.00 - 13.00

13.00 - 13.45 Significant Milestones in CML Treatment - NOVARTIS SATELLITE Chair:Birol Güvenç Speaker: Güray Saydam

SESSION VI - ACUTE LYMPHOID LEUKEMIAS CHAIR: Dieter Hoelzer, Deniz Sargın, Mustafa Yenerel

13.45 - 14.15 ALL Therapy: Essential Elements for Proper Treatment Dieter Hoelzer

COFFEE BREAK

18 OCTOBER 2018

LUNCH BREAK

MEET THE EXPERT SESSION & ORAL PRESENTATIONS - ROOM 1 - Angelo Maiolino (MM) / ROOM 2 - Tapan Kadia (MDS) / ROOM 3 - Nitin Jain (ALL) -

Chairs: Emin Kaya, Mahmut Töbü, Pervin Topçuoğlu

14.15 - 14.45 Diagnostic And Prognostic Markers in ALL Robin Foà

14.45 - 15.15 New Monoclonal Antibodies in ALL Nitin Jain

15.15 - 15.35Debate: Ph-Positive Acute Lymphoblastic Leukemia: Will We Still Need Chemotherapy and Stem

cell Transplantion? YesDieter Hoelzer

15.35 - 15.55Debate: Ph-Positive Acute Lymphoblastic Leukemia: Will We Still Need Chemotherapy and Stem

cell Transplantion? NoRobin Foà

15:55 - 16:30

SESSION VII - HEMATOLOGY SPECIALIST ASSOCIATION - HELLENIC SOCIETY OF HEMATOLOGY

JOINT SESSION

CHAIRS: Panayiotis Panayiotidis, Birol Güvenç, Sehmus

Ertop

16.30 - 17.00 New Therapeutic Options in CLL Panayiotis Panayiotidis

17.00 - 17.30 New Biomarkers in CLL TBA

17.30 - 18.00 Future Goals in CLL Therapy Robin Foà

COFFEE BREAK

18.00 - 19.00 POSTER PRESENTATIONS SESION 2 CHAIRS: Oktay Bilgir, Sami Kartı, İsmet Aydoğdu

07.30 - 08.15

SESSION VIII - APHERESIS SESSION CHAIRS: Robert Weinstein, Fevzi Altuntaş

08.30 - 09.00Apheresis in the Management of Hematological Disorders Using the Therapeutic Apheresis

Guidelines of the American Society for ApheresisJoseph Schwartz

09.00 - 09.30Medical Decision Making in Apheresis Medicine: When the Guidelines Do Not Cover Your Patient’s

ConditionRobert Weinstein

09.30 - 10.00Recent Advances in the Management of Thrombotic Thrombocytopenic Purpura (TTP) and Their

Effect on the Role of Apheresis in Its TreatmentRavi Sarode

10.00 - 10.30

SESSION IX - CHRONIC MYELOID LEUKEMIAS CHAIRS: Rudiger Hehlmann , Rıdvan Ali, Burhan Turgut

10.30 - 11.00 Impact of High-Risk Additional Chromoseme Aberration on Survival and Blast Crisis Rudiger Hehlmann

11.00 - 11.30 Are the Results that We Can Obtain with Imatinib All the Same in the World? Katia Pagnano

11.30 - 12.00 Treatment Discontinuation in Chronic Myeloid Leukemia, When and How ? Giuseppe Saglio

12:00 - 12:30 Response Monitoring in Chronic Myeloid Leukemia in the TFR Era Naeem Chaudhri

12.30 - 13.15 New Era with Carfilzomib in the Treatment of Relapsed / Refractory Multiple Myeloma - AMGEN SATELLITE Chair: Ali Ünal Speaker: Güray Saydam

COFFEE BREAK

19 OCTOBER 2018

MEET THE EXPERT SESSION & ORAL PRESENTATIONS - ROOM 1 - Carmino de Souza (NHL) / ROOM 2 - Tariq Mughal (CMD) / ROOM 3 - Dieter Hoelzer (ALL) Chairs: Gülsüm Özet, Atilla Özkan, Düzgün Özatlı

13.15 - 14.15

14.15 - 15.00 New Treatment Approaches in ALL Treatment - BMS SATELLITE Chair: Birol Güvenç Speaker: Mehmet Ali Özcan

SESSION X - SPECIAL TOPICS FOR NHL CHAIRS: Carmino de Souza, Burhan Ferhanoğlu

15.00 - 15.30 State of the Art of NHL Therapy Carmino de Souza

15.30 - 16.00 A Translational Perspective on Diffuse Large B-Cell Lymphoma Yücel Erbilgin

16.00 - 16.30 New Approaches in Marginal Zone Lymphoma Catherine Thieblemont

16.30 - 17.00 Mantle Cell Lymphoma, Blastic Variant; Diagnosis, Treatment Tayfur Toptaş

17.00 - 17.30

SESSION XI - AGGRESSIVE AND INDOLENT NH LYMPHOMAS CHAIRS: Catherine Thieblemont, Tayfur Toptaş

17.30 - 18.00 Essential Treatments of NHL Carmino de Souza

18.00 - 18.30 First-Line Treatment of Hodgkin Lymphoma Massimo Federico

18.30 - 19.00 Transplant in NHL; When? To Whom? Elif Birtaş Ateşoğlu

19.00 - 20.00 POSTER PRESENTATIONS SESION 3CHAIRS: Oral Nevruz, İhsan Karadoğan, Güven

Çetin

LUNCH BREAK

20 OCTOBER 2018

COFFEE BREAK

07.30 - 08.15

SESSION XII- CHRONIC LYMPHOCYTIC LEUKEMIAS AND INDOLENT LYMPHOMAS CHAIRS: Mehmet Turgut, Hakan Göker, Nilgün

Sayınalp

08.30 - 09.00 CLL Treatment Landscape in R/R CLL Patients in Scope of BCL-2 Inhibition Mehmet Ali Özcan

09.00 - 09.30 Chronic Lymphocytic Leukemia Old and New Treatments Panayiotis Panayiotidis

09.30 - 10.00 When and Why Chemo-Free Regimens in Mantle Cell Lymphoma Burhan Ferhanoğlu

10.00 - 10.30

SESSION XIII - STEM CELL TRANSPLANT AND CELLULAR THERAPY CHAIRS: Jean-Francois Rossi, Filiz Vural

10.30 - 11.00 Cancer Immunotherapy: Monoclonal antibodies from laboratory reagents to therapy Vera Donnenberg

11.00 - 11.30 Single cell surface proteomics for discovery of therapeutic targets Albert Donnenberg

11.30 - 12.00Impact of Posttransplant Hypomethelating Agnets on Cumulative Incidence Risk of Relapse After

Allotransplants for Myeloid Maligancies Khalid Halahleh

12.00 - 12.30 From Allogenic Transplantation to Precision Immune Therapy: The Role of Effector Cells Jean-Francois Rossi

12.30 - 13.00 Antifungal Management in Febril Neutropenia Ömrum Uzun

13.00 CLOSING

COFFEE BREAK

MEET THE EXPERT SESSION & ORAL PRESENTATIONS - ROOM 1 - Panayiotis Panayiotidis (CLL) / ROOM 2 - Massimo Federico (NHL) / ROOM 3 - Alessandro

Cignetti (AML) Chairs: Salih Aksu, Cengiz Ceylan, Mehmet Sönmez